INTRODUCTION {#s1}
============

Enchondromas are the most common primary benign osseous neoplasms of mature hyaline cartilage that occur within the medullary cavity of bone, and enchondromas account for 12 to 24 percent of all benign bone tumors and 3 to 10 percent of all bone tumors \[[@R1], [@R2]\]. Enchondromas occur predominantly in hands, typically in the middle and distal part of the metacarpals, and in the proximal part of the phalanges \[[@R3], [@R4]\]. Enchondromas can occur as solitary lesions or as multiple lesions (Ollier disease, Maffucci syndrome) \[[@R5], [@R6]\]. Multiple enchondromas can lead to malignant transformation more often (25-30%) than solitary enchondromas \[[@R7], [@R8]\]. The prevalence of Ollier\'s disease is estimated to be approximately 1 per 100, 000 people per year, and the incidence of malignant transformation has been estimated at 20-50% \[[@R9], [@R10]\]. Chondrosarcomas are the second most common type of malignant bone tumors after osteosarcomas \[[@R11]\]. Metastasis often takes place in high-grade chondrosarcomas and results in a poor survival rate \[[@R12]\]. Moreover, enchondromas and low-grade chondrosarcomas are usually histologically similar, so it is often impossible to distinguish them in clinics \[[@R13]\]. Therefore, finding out the molecular mechanism or biomarkers is necessary to help us understand the development of enchondromas and diagnose and treat enchondromas. Furthermore, targeting of key genes and pathways has been considered a promising approach in the diagnosis and treatment of cancer \[[@R14]\]. However, the molecular mechanism of enchondromas is unclear. Thus, identifying characteristic alerted genes and mechanisms associated with enchondromas is important for the inhibition of malignant transformation and the development of more effective therapies. Microarray techniques combined with bioinformatics analysis can determine the differential expression levels of genes accurately and provide an efficient method for large-scale gene expression studies \[[@R15]\]. Thus, analysis of gene expression profiling can provide a better understanding of molecular mechanisms and help to better diagnose or predict treatment response of patients with enchondroma.

In this study, by comparing the gene expression of enchondromas with normal growth plate and articular cartilage in the GEO database, we identified DEGs and performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment pathway analyses. In combination with protein--protein interaction (PPI) information, we not only identified relevant genes and pathways but also revealed existing molecular mechanisms. In conclusion, our analysis can improve our understanding of enchondroma and identify the key genes and pathways associated with diagnosis, prognosis, and treatment of enchondroma.

RESULTS {#s2}
=======

Identification of DEGs {#s2_1}
----------------------

The gene expression profile GSE22855 was downloaded from the GEO database, and the GEO2R method was used to identify DEGs in enchondroma samples compared with control samples. We used *P* \< 0.05, logFC (fold control) \> 1.0 or logFC \< -1.0 as the criteria, and 635 genes were identified as DEGs. Among these, 225 genes (35.43%) were up-regulated, and the remaining 410 genes (64.57%) were down-regulated. Subsequently, we created the heatmap using the top 50 up-regulated and down-regulated DEGs (Figure [1](#F1){ref-type="fig"}).

![The heat map of the DEGs (top 50 up-regulated and down-regulated genes)\
Enchondromas samples versus control samples. Changes in genes expression (*P* \< 0.05, logFC \> 1.0 or logFC \< -1.0) are illustrated by a heat map. Blue indicates a relatively low expression and red indicates a relatively high expression.](oncotarget-08-43967-g001){#F1}

GO term enrichment analysis {#s2_2}
---------------------------

Then, the online software DAVID was used to functionally categorize these 635 significant DEGs. GO analysis revealed that the up-regulated DEGs were significantly enriched in BP, including defense response to fungus, response to fungus, and defense response to Gram-positive bacterium (Table [1](#T1){ref-type="table"}); the down-regulated DEGs were significantly enriched in BP, including extracellular matrix organization, extracellular structure organization, and collagen metabolic process (Table [1](#T1){ref-type="table"}). For MF, the up-regulated DEGs were enriched in sulfur compound binding, glycosaminoglycan binding and heparin binding, and the down-regulated DEGs were enriched in extracellular matrix structural constituent, structural molecule activity, and growth factor binding (Table [1](#T1){ref-type="table"}). In addition, GO CC analysis also showed that the up-regulated DEGs were significantly enriched in the extracellular space, extracellular region part, and extracellular region, and down-regulated DEGs were enriched in the extracellular region part, extracellular region and extracellular matrix (Table [1](#T1){ref-type="table"}).

###### Gene ontology analysis of DEGs

  Expression       Category   GO-ID        Term                                                                      Gene count   \%     *P* value
  ---------------- ---------- ------------ ------------------------------------------------------------------------- ------------ ------ -----------
  Up-regulated     BP         GO:0050832   Defense response to fungus                                                11           5.6    9.20E-12
                   BP         GO:0009620   Response to fungus                                                        11           5.6    3.00E-10
                   BP         GO:0050830   Defense response to Gram-positive bacterium                               12           6.1    3.00E-09
                   BP         GO:0042742   Defense response to bacterium                                             18           9.1    7.00E-09
                   BP         GO:0009617   Response to bacterium                                                     25           12.7   2.30E-08
                   MF         GO:1901681   Sulfur compound binding                                                   16           8.1    4.30E-08
                   MF         GO:0005539   Glycosaminoglycan binding                                                 15           7.6    6.20E-08
                   MF         GO:0008201   Heparin binding                                                           13           6.6    1.80E-07
                   MF         GO:0050786   RAGE receptor binding                                                     4            2      1.90E-04
                   MF         GO:0016209   Antioxidant activity                                                      7            3.6    1.90E-04
                   CC         GO:0005615   Extracellular space                                                       56           28.4   1.10E-15
                   CC         GO:0044421   Extracellular region part                                                 89           45.2   4.00E-12
                   CC         GO:0005576   Extracellular region                                                      96           48.7   9.00E-11
                   CC         GO:0070062   Extracellular exosome                                                     68           34.5   1.10E-09
                   CC         GO:1903561   Extracellular vesicle                                                     68           34.5   1.40E-09
  Down-regulated   BP         GO:0030198   Extracellular matrix organization                                         37           11.6   3.00E-18
                   BP         GO:0043062   Extracellular structure organization                                      37           11.6   3.30E-18
                   BP         GO:0032963   Collagen metabolic process                                                20           6.3    1.30E-13
                   BP         GO:0044259   Multicellular organismal macromolecule metabolic process                  20           6.3    2.80E-13
                   BP         GO:0044259   Multicellular organism metabolic process                                  20           6.3    3.90E-12
                   MF         GO:0005201   Extracellular matrix structural constituent                               16           5      1.20E-11
                   MF         GO:0005198   Structural molecule activity                                              43           13.5   9.00E-11
                   MF         GO:0019838   Growth factor binding                                                     16           5      7.90E-09
                   MF         GO:0030020   Extracellular matrix structural constituent conferring tensile strength   6            1.9    9.90E-09
                   MF         GO:0005102   Receptor binding                                                          49           15.4   2.00E-05
                   CC         GO:0044421   Extracellular region part                                                 159          50     1.10E-25
                   CC         GO:0044421   Extracellular region                                                      171          53.8   3.10E-23
                   CC         GO:0031012   Extracellular matrix                                                      53           16.7   3.40E-22
                   CC         GO:0005578   Proteinaceous extracellular matrix                                        43           13.5   8.60E-21
                   CC         GO:0005788   Endoplasmic reticulum lumen                                               29           9.1    2.50E-16

Abbreviations: BP, Biological process; MF, Molecular function; CC, Cellular component.

KEGG pathway analysis {#s2_3}
---------------------

The result of KEGG analysis revealed that DEGs were enriched in ECM-receptor interaction, protein digestion and absorption, focal adhesion, PI3K-Akt signaling pathway and ribosomes, and the key genes involved in these pathways are summarized in Table [2](#T2){ref-type="table"}.

###### KEGG pathway analysis of DEGs

  Pathway-ID   Name                               Gene count   \%    *P* value   Genes
  ------------ ---------------------------------- ------------ ----- ----------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  4512         ECM-receptor interaction           18           3.5   3.60E-09    CHAD, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL6A3, COL11A1, COL11A2, ITGB5, LAMB2, TNC, THBS1, THBS2, THBS3, THBS4, VWF
  4974         Protein digestion and absorption   16           3.1   2.10E-07    FXYD2, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL9A1, COL9A2, COL9A3, COL6A3, COL11A1, COL11A2, COL12A1, PRCP, SLC7A8
  4510         Focal adhesion                     23           4.5   1.60E-06    JUN, CAV1, CAV2, CHAD, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL6A3, COL11A1, COL11A2, CCND3, ITGB5, LAMB2, PDGFD, TNC, THBS1, THBS2, THBS3, THBS4, VWF
  4151         PI3K-Akt signaling pathway         27           5.2   1.00E-04    MCL1, DDIT4, ATF4, CHAD, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL6A3, COL11A1, COL11A2, CCND3, CDK6, ITGB5, IFNA8, LAMB2, PCK2, PDGFD, RPS6, TNC, THBS1, THBS2, THBS3, THBS4, VWF
  3010         Ribosome                           15           2.9   2.00E-04    RPL13, RPL14, RPL21, RPL23, RPL37A, RPL5, RPL7, RPL7A, RPS15, RPS15A, RPS2, RPS28, RPS3A, RPS6, RPLP1

PPI Network of DEGs and core genes in the PPI network {#s2_4}
-----------------------------------------------------

Based on the information in the STRING database, the PPI network contained 393 nodes and 1534 edges. The nodes indicated the DEGs, and the edges indicated the interactions between the DEGs. The top 10 high-degree hub nodes included glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Jun proto-oncogene (JUN), matrix metallopeptidase 9 (MMP9), Fos proto-oncogene (FOS), collagen type I alpha 1 chain (COL1A1), early growth response 1 (EGR1), collagen type II alpha 1 chain (COL2A1), thrombospondin 1 (THBS1), forkhead box O1 (FOXO1) and collagen type I alpha 2 chain (COL1A2). Among these genes, GAPDH showed the highest node degree, which was 87. The core genes and their corresponding degree are shown in Table [3](#T3){ref-type="table"}. Then, we used MCODE to screen the modules of the PPI network (Figure [2](#F2){ref-type="fig"}), and we performed an enrichment analysis of the genes involved in the top two significant modules. The results showed that the DEGs in modules 1 and 2 were principally related to ribosomes, protein digestion and absorption, ECM-receptor interaction, focal adhesion, amoebiasis and PI3K-Akt signaling pathway (Table [4](#T4){ref-type="table"}).

###### The core genes and their corresponding degree

  Gene     Degree   Gene     Degree   Gene     Degree   Gene     Degree
  -------- -------- -------- -------- -------- -------- -------- --------
  GAPDH    87       EGR1     35       RUNX2    31       RPS2     26
  JUN      61       COL2A1   35       CTGF     29       RPL5     26
  MMP9     56       THBS1    32       RPS6     28       RPS15    26
  FOS      52       FOXO1    32       COL3A1   28       HSPA8    26
  COL1A1   41       COL1A2   31       VWF      27       COL4A1   26

![Top two modules from the PPI network\
The squares represent the DEGs in modules, and the lines show the interaction between the DEGs. The top two modules indicate that they may play a more important role in the PPI network. **(A)** module 1. **(B)** module 2.](oncotarget-08-43967-g002){#F2}

###### The enriched pathways of modules

  Modules   Enriched pathways                  *P* value   False discovery rate   Nodes
  --------- ---------------------------------- ----------- ---------------------- -------------------------------------------------------------------------------------------------------
  1         Ribosome                           1.90E-21    1.64E-27               RPL13, RPL14, RPL21, RPL23, RPL37A, RPL5, RPL7, RPL7A, RPS15, RPS15A, RPS2, RPS28, RPS3A, RPS6, RPLP1
  2         Protein digestion and absorption   7.50E-22    1.31E-24               COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL9A1, COL9A2, COL9A3, COL6A3, COL11A1, COL12A1
            ECM-receptor interaction           1.20E-11    5.71E-14               COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL6A3, COL11A1
            Focal adhesion                     5.60E-09    3.42E-11               COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL6A3, COL11A1
            Amoebiasis                         4.90E-09    3.42E-11               COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL11A1
            PI3K-Akt signaling pathway         3.20E-07    1.63E-09               COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL6A3, COL11A1

DISCUSSION {#s3}
==========

Enchondromas are benign cartilaginous neoplasms that commonly occur in medullary bone \[[@R1]\]. These tumors can occur at any age, and they are found most commonly in children and adolescents with no significant sex differences \[[@R16]\]. Additionally enchondromas can undergo malignant transformation into chondrosarcoma \[[@R17], [@R18]\]. However, because they are clinically silent, enchondromas remain undetected in patients, and few studies address the molecular mechanism of enchondromas \[[@R19]\]. In the current study, the gene expression profile of GSE22855 was downloaded and a bioinformatic analysis was performed. The analysis results showed that there were 635 differentially expressed genes in the enchondroma samples compared with the control samples. Furthermore, GO, KEGG pathway and PPI analyses were performed to obtain a better understanding of this tumor, which was easily ignored.

The results of GO analyses showed that the significant ontology categories of up-regulated DEGs included defense response to fungus, sulfur compound binding and heparin binding. A previous study showed that garlic can detoxify carcinogens by stimulation of sulfur compound binding \[[@R20]\]. Moreover, up-regulation of genes associated with glycosaminoglycan binding was also found in ovarian cancer \[[@R21]\]. A recent study suggested that blocking heparan sulfate (HS) interaction with the heparin-binding domains of fibroblast growth factor receptors (FGFRs) could inhibit cancer cell growth \[[@R22]\]. Furthermore, down-regulated DEGs were mainly related to extracellular matrix organization, the extracellular matrix structural constituent and the collagen metabolic process. Elevation of genes associated with extracellular matrix organization could also be found in well-differentiated squamous cell carcinoma and colorectal cancer \[[@R23], [@R24]\]. Another analysis of secretome profiles on cancer-associated fibroblasts showed that up-regulated proteins were involved mainly in extracellular matrix organization and disassembly and collagen metabolism \[[@R25]\]. Therefore, GO analysis can help identify the possible biological processes, molecular functions and cellular components involved in the occurrence and development of enchondromas.

Moreover, the KEGG pathways revealed that DEGs were enriched in ECM-receptor interaction, protein digestion and absorption, focal adhesion, the PI3K-Akt signaling pathway and ribosomes. As a member of the basic helix-loop-helix (bHLH) family which plays a key role in tumorigenesis, Twist2 could promote proliferation and invasion of kidney cancer cell via regulating the ECM-Receptor-Interaction pathway \[[@R26]\]. The protein digestion and absorption pathway has been reported to be associated with pancreatic neuroendocrine tumors and breast cancer \[[@R27], [@R28]\]. Focal adhesion has been verified as taking part in cell migration in various tumor cells \[[@R29]--[@R31]\]. The phosphatidylinositol-3 kinases/Akt (PI3K/Akt) signaling pathway is activated in many human tumors, and it was proved to be a promising anticancer target \[[@R32]\]. Thus, deep understanding of the pathways can help us to elucidate the crucial mechanism of enchondromas.

Furthermore, we analyzed the PPI network and found that GAPDH, JUN, MMP9, FOS, COL1A1, EGR1, COL2A1, THBS1, FOXO1 and COL1A2 were the top 10 core genes, which may be potential therapeutic targets for enchondromas. GAPDH showed the highest node degree among these genes. GAPDH is deregulated in various cancer cells, and it is a new therapeutic target associated with tumor progression \[[@R33]\]. Therefore, experimental studies on GAPDH are essential to understand its role in the molecular mechanisms of enchondromas. C-jun was an important oncogene that could provide signals for cell survival; it was highly overexpressed in various invasive cancers, and repression of c-jun was beneficial to inhibiting the development and progression of cancer \[[@R34], [@R35]\]. MMP9 has been shown to be involved in the migration and invasion of various tumors, including breast cancer, transitional cell carcinoma, and non-small cell lung cancer \[[@R36]--[@R39]\]. A recent study revealed that epigenetic down-regulation of COL1A1 mRNA expression might have a role as a prognostic biomarker of hepatocellular carcinoma \[[@R40]\]. Expression profiles of COL2A1 and COL1A2 were independent predictors of survival in ovarian cancer and head and neck cancer respectively \[[@R41], [@R42]\]. EGR1 isn\'t only a tumor suppressor gene (TSG) but also a gene with oncogenic activities \[[@R43]\], so understanding how it changes in enchondromas helps us to elucidate the crucial mechanism of tumorigenesis. As a tumor-specific ECM protein, THBS1 could promote migration of cancer cells and cause activation of integrin signaling in oral squamous cell carcinoma \[[@R44]\]. FOXO1 was a key effector of PI3K/Akt signaling and functions as tumor suppressors \[[@R45]\]. Therefore, the analysis of these core genes is useful for understanding the molecular mechanisms and identifying therapeutic targets of enchondromas.

Moreover, two main modules were got from the module analysis of the PPI network, and enrichment analysis showed that the modules were involved in ribosomes, protein digestion and absorption, ECM-receptor interaction, focal adhesion, amoebiasis and the PI3K-Akt signaling pathway. These results agreed with those of the KEGG analysis, and these related pathways represented promising candidates for therapeutic intervention and prognostic evaluation.

Somatic mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) have been detected in secondary glioblastomas, gliomas and acute myeloid leukemia (AML) \[[@R46]--[@R48]\]. IDH1 and IDH2 mutations are identified as the first common genetic abnormalities in conventional central and periosteal cartilaginous tumors, including enchondromas \[[@R49]\]. IDH1 mutations usually result in substitutions at R132, whereas IDH2 mutations affect R172, R132 and R140 \[[@R49], [@R50]\]. Moreover, the mutations occur in the early stages of tumorigenesis and can cause the accumulation of D-2-hydroxglutarateare \[[@R51]\]. The overall frequency of IDH1/IDH2 mutations was approximately 56% in conventional central and periosteal cartilaginous neoplasms \[[@R49]\]. Furthermore, a previous study showed that DNA hypermethylation was a consequence of IDH1/IDH2 mutations in AML and could result in reduced haemopoietic cellular differentiation and loss of markers related to proliferation \[[@R52]\]. Previous studies have demonstrated both positive and negative correlations between intragenic DNA methylation and gene expression, and abnormal DNA methylation was considered a common mechanism in the pathogenesis of several types of tumors \[[@R53]--[@R56]\]. Therefore, the researches on the impact of DNA methylation on gene expression in enchondromas are quite necessary. In our analysis, IDH1 and IDH2 were also identified as DEGs, and the results of these previous studies provided support for the result of our analysis. Furthermore, it is essential to explore the significant mutations and aberrant DNA methylation that occur in enchondromas, as they appear to be helpful for understanding the genetic alterations and molecular mechanisms of enchondromas.

SNP arrays are a useful research tool in molecular biology that can provide an analysis of DNA copy number alterations (CNA) and loss of heterozygosity (LOH); it can also detect genetic alterations in tumors \[[@R57], [@R58]\]. A previous study used the SNP array in combination with an expression array and aimed to obtain a comprehensive registry of genetic aberrations; the results demonstrated that CNA and LOH are rare and non-recurrent in enchondromas \[[@R59]\]. This study mainly studied genetic alterations including CAN and LOH, while our study mainly studied the global changes in gene expression and attempted to explore the molecular mechanisms underlying enchondromas. Furthermore, another study performed immunohistochemical analysis and quantitative real-time polymerase chain reaction (PCR) to reach a better understanding of the molecular mechanisms underlying malignant transformation of enchondromas; the result demonstrated that parathyroid hormone related peptide (PTHrP) signaling is active in enchondromas, and the PTH type 1 receptor (PTHR1) and B-cell lymphoma-2 (Bcl-2) were associated with tumor progression \[[@R7]\]. Another article performed a genome-wide cDNA expression analysis and found that Ollier\'s disease and solitary enchondromas revealed similar expression profiles; JunB may be of diagnostic relevance to grade I chondrosarcomas \[[@R60]\]. This result was also supported by our study that JunB was also a DEG in our study. In addition, the increase in glycolysis-associated genes and decrease in oxidative phosphorylation-related genes was found in high-grade chondrosarcoma and these genes were considered to be associated with chondrosarcoma progression \[[@R60]\]. Compared with previous studies, the present study found several novel genes, such as GAPDH, MMP9, FOS, COL1A1 and EGR1, which might be potentially associated with enchondromas. We also discovered potential PPIs between these genes, and if the roles of these genes in enchondromas are confirmed, the genes could potentially be utilized in the molecular diagnosis or treatment selection of enchondromas.

This study had several limitations. First, the sample sizes for the expression profiling were not large, so further studies with larger sample sizes are needed to verify the results. Second, it is acknowledged that predicting key genes merely by means of bioinformatics is not sufficient, and further molecular biological experiments are needed to confirm these results. Therefore, we hope that these data can be incorporated into future experiments; the results can give us a better understanding of the molecular mechanisms and provide novel biomarkers for the molecular therapy of enchondromas. Despite these limitations, we believe that this analysis represents a valuable resource and may be meaningful for further diagnosis and therapy for this disease.

CONCLUSION {#s4}
==========

In conclusion, the present study identified 635 DEGs, which may be involved in the occurrence and development of enchondromas via comprehensive bioinformatics analysis. GO term, KEGG pathway and PPI network analyses provided a set of related genes and pathways to help elucidate the molecular mechanisms of enchondromas. Further experimental studies are needed to confirm these results and should help determine potential targets for diagnosis, prognosis, and treatment of enchondroma.

MATERIALS AND METHODS {#s5}
=====================

Gene expression microarray data {#s5_1}
-------------------------------

In current study, the gene expression profiles of GSE22855 were downloaded from Gene Expression Omnibus (GEO, <http://www.ncbi.nlm.nih.gov/geo/>). GSE22855 was based on Illumina Inc GPL6884 platform (Illumina HumanWG-6 v3.0 expression beadchip). The GSE22855 dataset contained 13 samples, including 7 enchondromas samples and 6 control samples.

Identification of DEGs {#s5_2}
----------------------

The raw data files used for the analysis included TXT files (Illumina platform). The analysis was carried out using GEO2R, which can perform comparisons on original submitter-supplied processed data tables using the GEOquery and limma R packages from the Bioconductor project. The DEGs between the enchondromas samples and control samples were selected (P value \< 0.05), and overlapped genes with statistical significance were identified.

GO enrichment and KEGG pathway analysis of the DEGs {#s5_3}
---------------------------------------------------

After identifying the DEGs, we submitted the DEGs list to the online software Database for Annotation, Visualization and Integrated Discovery (DAVID, <https://david.ncifcrf.gov/>) to identify overrepresented GO categories and pathway categories. GO analysis can provide quantitative and statistical output files to determine the biological meaning in a large list of genes and categorize gene product functions, including biological process (BP), molecular function (MF) and cellular component (CC) \[[@R61], [@R62]\]. KEGG (<http://www.genome.jp/>) is a knowledge base for systematic analysis of gene functions, linking genomic information with higher-level systemic functions \[[@R63], [@R64]\]. Finally, the enriched functions of DEGs were selected via GO and KEGG pathway analysis, and *P* \< 0.05 was considered statistically significant.

Construction of the PPI network of DEGs {#s5_4}
---------------------------------------

To further investigate the molecular mechanism of enchondromas in development and progression, we used the Search Tool for the Retrieval of Interacting Genes (STRING) database (<http://www.string-db.org/>) to evaluate the interactive relationships among DEGs. We first submitted the DEGs list to STRING, and then, we selected the experimentally validated interactions with a combined score \> 0.4. Subsequently, the PPI networks were analyzed using Cytoscape software. Then, the plug-in Molecular Complex Detection (MCODE) was applied to screen the modules of the PPI network in Cytoscape. Furthermore, the enrichment analyses were performed for DEGs in the corresponding modules. *P* \< 0.05 was considered statistically significant.
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